Print This Page

• CPTC Experts Author Proteomics Review in the Journal of Proteome Research

  CPTC experts authored a review of the current state of clinical proteomics

• 

  CPTC Hosts Fourth Annual Meeting on Establishing the Standards in Clinical Proteomics

  CPTC held its fourth annual meeting in Bethesda, MD, on September 8-9, 2010, bringing together a record number of attendees-more than 300 participants-representing the full breadth of scientific fields that contribute to the initiative's mission.

• 

  An Interview with the President-Elect of the American Association for Clinical Chemistry

  The AACC has a number of key goals as it moves into 2011 including: developing ways to continue working with industry within the new AdvaMed guidelines; developing ways in which the AACC can collaborate more with other professional medical associations; increasing the recognition of translational science at our annual meeting; and continuing our global outreach

• 

  Integrating Genomics with Proteomics: Towards a Comprehensive View of Cancer Biology

  Approximately 60 percent of patients diagnosed with cancer present as early stage disease (Stage I and II). Despite the favorable prognosis associated with treatment intervention of such early stage disease (typically surgical excision), there are a small, but significant, fraction of these cancers that appear to be hardwired for aggressive metastatic behavior and ultimately lethal outcome.

• Phase II of CPTC Initiative

  "Cancer is a disease of the genome," noted Lynda Chin, M.D., professor of dermatology, Harvard Medical School and Dana-Farber Cancer Institute. "And understanding the impact of genomic changes in the proteome is critically important for converting genomic knowledge into something that a clinician can use on their patients."

• 1